Literature DB >> 23863175

The structural mechanisms that underpin mitotic kinase activation.

Charlotte A Dodson1, Tamanna Haq, Sharon Yeoh, Andrew M Fry, Richard Bayliss.   

Abstract

In eukaryotic cells, the peak of protein phosphorylation occurs during mitosis, switching the activities of a significant proportion of proteins and orchestrating a wholesale reorganization of cell shape and internal architecture. Most mitotic protein phosphorylation events are catalysed by a small subset of serine/threonine protein kinases. These include members of the Cdk (cyclin-dependent kinase), Plk (Polo-like kinase), Aurora, Nek (NimA-related kinase) and Bub families, as well as Haspin, Greatwall and Mps1/TTK. There has been steady progress in resolving the structural mechanisms that regulate the catalytic activities of these mitotic kinases. From structural and biochemical perspectives, kinase activation appears not as a binary process (from inactive to active), but as a series of states that exhibit varying degrees of activity. In its lowest activity state, a mitotic kinase may exhibit diverse autoinhibited or inactive conformations. Kinase activation proceeds via phosphorylation and/or association with a binding partner. These remodel the structure into an active conformation that is common to almost all protein kinases. However, all mitotic kinases of known structure have divergent features, many of which are key to understanding their specific regulatory mechanisms. Finally, mitotic kinases are an important class of drug target, and their structural characterization has facilitated the rational design of chemical inhibitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863175     DOI: 10.1042/BST20130066

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

Review 1.  Centrosomes and cancer: revisiting a long-standing relationship.

Authors:  Pierre Gönczy
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

2.  Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.

Authors:  Amanda Tse; Gennady M Verkhivker
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

3.  Checkpoint signaling and error correction require regulation of the MPS1 T-loop by PP2A-B56.

Authors:  Davinderpreet Mangat; Tatiana Alfonso-Pérez; Daniel Hayward; James Bancroft; Sholto Dugdale; Julia McCarthy; Francis A Barr; Ulrike Gruneberg
Journal:  J Cell Biol       Date:  2019-09-11       Impact factor: 10.539

4.  Characterization of the human NEK7 interactome suggests catalytic and regulatory properties distinct from those of NEK6.

Authors:  Edmarcia Elisa de Souza; Gabriela Vaz Meirelles; Bárbara Biatriz Godoy; Arina Marina Perez; Juliana Helena Costa Smetana; Stephen J Doxsey; Mark E McComb; Catherine E Costello; Stephen A Whelan; Jörg Kobarg
Journal:  J Proteome Res       Date:  2014-08-13       Impact factor: 4.466

5.  A Cell Biologist's Field Guide to Aurora Kinase Inhibitors.

Authors:  Christian O de Groot; Judy E Hsia; John V Anzola; Amir Motamedi; Michelle Yoon; Yao Liang Wong; David Jenkins; Hyun J Lee; Mallory B Martinez; Robert L Davis; Timothy C Gahman; Arshad Desai; Andrew K Shiau
Journal:  Front Oncol       Date:  2015-12-21       Impact factor: 6.244

6.  Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.

Authors:  Yuan Xie; Jian-Zhen Lin; An-Qiang Wang; Wei-Yu Xu; Jun-Yu Long; Yu-Feng Luo; Jie Shi; Zhi-Yong Liang; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2017-08-21       Impact factor: 5.742

7.  Insights into evolutionary interaction patterns of the 'Phosphorylation Activation Segment' in kinase.

Authors:  Adil Ahiri; Hocine Garmes; Crtomir Podlipnik; Aziz Aboulmouhajir
Journal:  Bioinformation       Date:  2019-10-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.